Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of normal release morphine in the management of dyspnoea
2004-004620-12Phase 2Terminated
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of morphine in Dyspnoea (SOB), sponsored by Royal Marsden NHS Foundation Trust. Primary endpoint: Optimal morphine dose for dyspnoea relief. Started Feb 2005; status: terminated.
02
Drugs
morphine
03
Conditions
Dyspnoea (SOB)
Beyond the preview
Go deeper on 2004-004620-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004620-12.